Search Results

Obeticholic Acid 25 mg  | 99.78%

TargetMol

Obeticholic Acid (6-ECDCA) is a Farnesoid X Receptor Agonist. The mechanism of action of obeticholic acid is as a Farnesoid X Receptor Agonist.

More Information Supplier Page

Obeticholic Acid 10 mg  | 99.78%

TargetMol

Obeticholic Acid (6-ECDCA) is a Farnesoid X Receptor Agonist. The mechanism of action of obeticholic acid is as a Farnesoid X Receptor Agonist.

More Information Supplier Page

2′-Deoxyuridine 100 mg  | 99.88%

TargetMol

2′-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies.

More Information Supplier Page

SCR7 pyrazine 10 mg  | 99.83%

TargetMol

Enhances CRISPR-Cas9-mediated homology-directed repair (HDR) efficiency in vitro up to 19-fold. Inhibits nonhomologous end-joining (NHEJ).

More Information Supplier Page

SCR7 pyrazine 25 mg  | 99.83%

TargetMol

Enhances CRISPR-Cas9-mediated homology-directed repair (HDR) efficiency in vitro up to 19-fold. Inhibits nonhomologous end-joining (NHEJ).

More Information Supplier Page

SCR7 pyrazine 50 mg  | 99.83%

TargetMol

Enhances CRISPR-Cas9-mediated homology-directed repair (HDR) efficiency in vitro up to 19-fold. Inhibits nonhomologous end-joining (NHEJ).

More Information Supplier Page

SCR7 pyrazine 5 mg  | 99.83%

TargetMol

Enhances CRISPR-Cas9-mediated homology-directed repair (HDR) efficiency in vitro up to 19-fold. Inhibits nonhomologous end-joining (NHEJ).

More Information Supplier Page